Resveratrol, Metabolic Dysregulation, and Alzheimer’s Disease: Considerations for Neurogenerative Disease
Alzheimer’s disease (AD) has traditionally been discussed as a disease where serious cognitive decline is a result of A<i>β</i>-plaque accumulation, tau tangle formation, and neurodegeneration. Recently, it has been shown that metabolic dysregulation observed with insulin resistance and...
Main Authors: | Alex J. T. Yang, Ahmed Bagit, Rebecca E. K. MacPherson |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-04-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/22/9/4628 |
Similar Items
-
Research Progress on the Regulation of Resveratrol on Alzheimer’s Disease
by: WU Liangwen, ZHANG Hu, WU Tong, CHEN Ning
Published: (2023-02-01) -
Brain targeting based nanocarriers loaded with resveratrol in Alzheimer's disease: A review
by: Cyrus Jalili, et al.
Published: (2023-05-01) -
Resveratrol: An Antiaging Drug with Potential Therapeutic Applications in Treating Diseases
by: Mercè Pallàs, et al.
Published: (2009-12-01) -
Resveratrol as a potential protective compound against skeletal muscle insulin resistance
by: Arash Bahramzadeh, et al.
Published: (2023-11-01) -
Neuroprotective Effects of Chronic Resveratrol Treatment and Exercise Training in the 3xTg-AD Mouse Model of Alzheimer’s Disease
by: Tom L. Broderick, et al.
Published: (2020-10-01)